XENON PHARMACEUTICALS INC (XENE) Stock Income Statement
NASDAQ:XENE - CA98420N1050 - Common Stock
38.62 USD
-0.02 (-0.05%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.50M | 0.00 | 0.00 | 9.43M | 18.44M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 325.62M | 279.30M | 214.05M | 138.58M | 97.43M | |||
| Research and Development | 252.63M | 210.39M | 167.51M | 105.77M | 75.46M | |||
| Selling, General, and Administrative Expenses | 72.99M | 68.90M | 46.54M | 32.81M | 21.97M | |||
| Operating Income | -318.12M | -279.30M | -214.05M | -129.14M | -78.99M | |||
| Interest Income/Expense | 35.52M | 40.88M | 31.37M | 3.89M | 110.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Income Before Taxes | -282.60M | -238.42M | -182.69M | -125.26M | -78.89M | |||
| Income Tax | -4.37M | -4.09M | -292.00K | 120.00K | -10.00K | |||
| Net Income | -278.23M | -234.33M | -182.39M | -124.94M | -77.09M | |||
| EBITDA | -315.53M | -276.74M | -211.99M | -127.52M | -78.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.54 | -3.01 | -2.73 | -2.06 | -1.77 | |||
| Non GAAP EPS | -3.55 | -3.02 | -2.72 | -2.04 | -1.77 | |||
| Statistics | ||||||||
| Profit Margin | -3709.71% | N/A | N/A | -1324.92% | -418.06% | |||
| Operating Profit Margin | -4241.60% | N/A | N/A | -1369.46% | -428.36% | |||
All data in USD